Where does Vanrx Pharmasystems Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Vanrx Pharmasystems Inc. ranks #7,212 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Vanrx Pharmasystems Inc. hold?

Vanrx Pharmasystems Inc. holds 46 US utility patents granted between 2017 and 2024, spanning 19 technology areas.

What is Vanrx Pharmasystems Inc.'s Innovation Score?

Vanrx Pharmasystems Inc. has an Innovation Score of 47.7 out of 100 (top 18% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Vanrx Pharmasystems Inc. focus on?

Vanrx Pharmasystems Inc.'s top technology area is B65B (Machines, Apparatus OR Devices FOR, OR Methods OF, Packaging Articles OR MATERIALS; Unpacking) with 38 patents, ranking #24 of 1,343 assignees active in that subclass. Grants appear in 19 CPC subclasses total.

Is Vanrx Pharmasystems Inc.'s patent grant rate increasing or decreasing?

Vanrx Pharmasystems Inc.'s recent grant velocity is +457% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Vanrx Pharmasystems Inc.'s patents?

Vanrx Pharmasystems Inc.'s patents average 22.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Vanrx Pharmasystems Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Vanrx Pharmasystems Inc.

USPTO PatentsView assignee record - 46 granted patents across 19 technology areas, recorded in grant years 2017–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: B65B (Machines, Apparatus OR Devices FOR, OR Methods OF, Packaging Articles OR MATERIALS; Unpacking).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Vanrx ranks #7,212 of 49,997 tracked US assignees by granted-patent volume, with 46 patents across 19 technology areas.

#7,212
of 49,997 US assignees by volume: Top 18%
by Innovation Score (47.7/100): 22.4
avg claims per patent: +457%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R7212 · Foreign Corporation #7,212 · 46 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 46 grants
UPPER-Q #7,212/49,997
PHOTO-FINISH Unigen
CPC-FOCUS B65B · 19 areas
INNOV-PAR 47.7/100
CLAIMS-DENSE 22.4 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +457% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Unigen, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Vanrx’s 47.7 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 13.3 pts (28%) Velocity 5.5 pts (12%) Breadth 15.4 pts (32%) Claim depth 13.5 pts (28%)

Qualcomm Incorporated · highest

85
Chimei · near

48
ROVl Guides · near

48
South China Normal… · near

48
TRON—Translationale… · near

48
Vanrx Pharmasystems · this assignee

48
3D Lighting… · lowest

7

What this shows Vanrx's Innovation Score is 47.7/100 (top 18% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Vanrx?

Each dot is one of Vanrx’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Vanrx’s own 22.4 claims/patent is ABOVE the 14.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Vanrx vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Vanrx's grants concentrate

Vanrx Pharmasystems Inc. is a focused PatentsView assignee: 19 CPC subclasses with 82.6% of grants classified under B65B (Machines, Apparatus OR Devices FOR, OR Methods OF, Packaging Articles OR MATERIALS; Unpacking). Peak complete grant year is 2020 (11 grants) versus a trough of 1 in 2017. By volume, Vanrx sits between University College CORK—NATIONAL University OF Ireland, Cork and Windbond Electronics Corp..

Vanrx's three-year grant acceleration

From 2019–2021 to 2022–2024, Vanrx Pharmasystems Inc. moved from 23 to 19 grants (0.83x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

University Colleg…

46
UniversitÉ Libre…

46
UPM Raflatac OY

46
Unigen

46
Vishay Dale

46
Vision Works IP

46
W M Barr &

46
Windbond

46
Vanrx Pharmasyste… ◀

46

What this shows Vanrx holds 46 patents at rank #7,211, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Vanrx

By rank, the assignees closest to #7,211 in granted patent volume.

Leaders in B65B (Machines)

Other assignees with the most granted patents in Vanrx's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Vanrx, neither rank-band nor same-CPC leaders (those blocks stay above). In B65B (Machines), Vanrx ranks #24 of 1,343 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (48 here).

TRON—Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz 48 South China Normal University 48 ROVl Guides, Inc. 48 Chimei Corporation 48

Vanrx's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

48 Top 18% higher than 82% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Vanrx Pharmasystems Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	1	2.2%
2018	3	6.5%
2019	3	6.5%
2020	11	23.9%
2021	9	19.6%
2022	6	13.0%
2023	3	6.5%
2024	10	21.7%

Which technologies does Vanrx Pharmasystems Inc. patent most?

B65B - Machines, Apparatus OR Devices FOR, OR Methods OF, Packaging Articles OR MATERIALS; Unpacking 38

B25J - MANIPULATORS; Chambers Provided With Manipulation Devices 25

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 19

A61J - Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle 15

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 11

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 10

C12M - Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Fermenters 10

B65D - Containers FOR Storage OR Transport OF Articles OR Materials, e.g. Bags, Barrels, Bottles, Boxes, Cans, Cartons, Crates, Drums, Jars, Tanks, Hoppers, Forwarding CONTAINERS; Accessories, Closures, OR Fittings THEREFOR; Packaging ELEMENTS; Packages 9

G06F - Electric Digital Data Processing 4

H04M - Telephonic Communication 4

G01F - Measuring Volume, Volume Flow, Mass Flow OR Liquid LEVEL; Metering BY Volume 4

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 3

B67C - Cleaning, Filling With Liquids OR Semiliquids, OR Emptying, OF Bottles, Jars, Cans, Casks, Barrels, OR Similar Containers, NOT Otherwise Provided FOR; Funnels 3

B67B - Applying Closure Members TO Bottles Jars, OR Similar CONTAINERS; Opening Closed Containers 3

B65G - Transport OR Storage Devices, e.g. Conveyors FOR Loading OR Tipping, Shop Conveyor Systems OR Pneumatic Tube Conveyors 3

Top 15 of 19 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Vanrx Pharmasystems Inc.'s patent record in context - here's where to go next.

Vanrx Pharmasystems Inc.'s lead technology class is B65B (Machines, Apparatus OR Devices FOR, OR Methods OF, Packaging Articles OR MATERIALS; Unpacking), 82.6% of its portfolio - see every assignee active in that class. Explore B65B
Ranked #7,212 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Vanrx Pharmasystems Inc. against University College CORK—NATIONAL University OF Ireland, Cork, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 47.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.